英特格拉生命科学 IART 深 沪
等待开盘 11-07 09:30:00 美东时间
11.22
-0.180
-1.58%
华盛通- 最 高11.33
- 今 开11.29
- 成交量 134.85万股
- 最 低 11.01
- 昨 收 11.40
- 总市值 8.74亿
- 52周最高 27.13
- 市盈率 静 --
- 换手率 1.73%
- 52周最低 10.87
- 委 比 -85.09%
- 总股本 7791.08万
- 历史最高 77.40
- 量 比 0.61
- 振 幅 2.81%
- 历史最低 8.36
- 每 手 1
- 风险率 4.94%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 高盛上调英伟达目标价升至240美元； Loop Capital上调英伟达目标价升至350美元！
今日重点评级关注：花旗：维持Caribou Biosciences"买入"评级，目标价从5美元升至8美元；HC Wainwright & Co.：上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入"，目标价30美元
11-04 10:31
美股大行评级 | 苹果、亚马逊、Cloudflare、西部数据、Twilio等获十多家机构集体上调目标价；杰富瑞首予Cloudflare"持有"评级，目标价250美元
今日重点评级关注：康托·菲茨杰拉德：维持Cabaletta Bio"超配"评级，目标价从15美元升至30美元；HC Wainwright & Co.：维持Invivyd"买入"评级，目标价从5美元升至10美元
11-03 20:20
JP Morgan Maintains Underweight on Integra Lifesciences, Raises Price Target to $13
JP Morgan analyst Robbie Marcus maintains Integra Lifesciences (NASDAQ:IART) with a Underweight and raises the price target from $12 to $13.
11-01 02:40
Earnings Scheduled For October 30, 2025
Companies Reporting Before The Bell • Altria Group (NYSE:MO) is projected to re...
10-30 19:12
Integra Lifesciences Narrows FY2025 Adj EPS Guidance from $2.19-$2.29 to $2.19-$2.24 vs $2.21 Est; Lowers FY2025 Sales Guidance from $1.655B-$1.680B to $1.620B-$1.640B vs $1.669B Est
Integra Lifesciences (NASDAQ:IART) narrows FY2025 Adj EPS guidance from $2.19-$2.29 to $2.19-$2.24 vs $2.21 analyst estimate. Lowers FY2025 sales outlook from $1.655 billion-$1.680 billion to $1.620 billion-$1.640
10-30 18:01
Integra LifeSciences Advances with MIRROR Registry Study on Hematoma Evacuation
Integra Lifesciences (($IART)) announced an update on their ongoing clinical st...
10-28 03:20
Bharti Airtel Penalized for Subscriber Verification Violations
Bharti Airtel Limited ( ($IN:BHARTIARTL) ) has issued an update. Bharti Airtel ...
10-25 13:52
美股大行评级 | 贝莱德、花旗、摩根大通、富国银行均获上调目标价！汇丰上调超微公司目标价升至310美元
今日重点评级关注：Roth Capital：维持Cingulate"买入"评级，目标价从10美元升至17美元；JMP证券：维持BioCryst Pharma"跑赢大市"评级，目标价从17美元升至27美元
10-16 10:43
Truist Securities Maintains Hold on Integra Lifesciences, Raises Price Target to $15
Truist Securities analyst Richard Newitter maintains Integra Lifesciences (NASDAQ:IART) with a Hold and raises the price target from $13 to $15.
10-15 23:14
谷歌计划在印度投资150亿美元建设数据中心，系其在印最大投资
字母表公司（Alphabet Inc．，股票代码：GOOG、GOOGL）旗下的谷歌计划在未来五年内，投资约 150 亿美元在印度南部建设一个人工智能基础设施...
10-14 16:33
